| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.41 | 0.005 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |